Vaccine makers targeting COVID-19 to measles will come under investor scrutiny on Tuesday as a group of independent experts at the CDC are scheduled to meet for the first time to review U.S.

The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and ...

University of Delaware's Mona Batish is a molecular biologist. She studies circular RNAs formed as a result of so-called ...

A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

The identification and intervention of Alzheimer's Disease (AD) in its early-stage allows for the timely implementation of lifestyle modifications and therapeutic strategies. Although dysregulation of ...

In the default model, the graph representing each individual enhancer can be arbitrarily complicated. To show how the ABC Score formula can arise from the default model, we need to impose the further ...

Home > Pressemitteilung: New solutions for the RNA medicine of ... At the RNApp graduate school, young researchers are working to make RNA-based drugs safer and more effective.

RNA epigenetic modifications have uncovered as not only an intermediary structure between DNA and protein or an effector ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Moderna (NasdaqGS:MRNA) recently experienced a 17% decline in share price over the past week, a significant downturn that occurs amidst market-wide turbulence triggered by escalating global trade ...

Flagship Pioneering-backed Sail Biomedicines has laid off 12 employees following a review of the company’s organizational ...

In horses, no such signal was found in the KEAP1 transcript. Yet the translation continued. One likely explanation lies in the structure of the KEAP1 mRNA itself. The end of the transcript forms a ...